インドの伝統医療市場の評価：医療システム別、サブセクター別、由来別、用途別、投与経路別、流通チャネル別、地域別、機会、予測、2017年～2031年

インドの伝統医療の市場規模は、2023年に275億3,000万米ドルとなりました。同市場は、2024年から2031年までの予測期間に13％のCAGRで拡大し、2031年には731億9,000万米ドルに達すると予測されています。インド伝統医療市場成長の1次促進要因としては、伝統医療の費用対効果、患者の個人的信条との一致、合成薬の潜在的副作用に対する懸念の緩和、個別化医療への要望の充足、健康知識への幅広い一般市民のアクセスの促進、自然で安全であるという一般的認識、統合医療研究によって裏付けられた特定のハーブ療法の有効性と安全性などが挙げられます。

インドの伝統医療市場の拡大は、患者とヘルスケア部門の双方に深く共鳴する要因が複雑に絡み合っていることに根ざしています。基本的な原動力は、伝統的な医療行為に内在する費用対効果です。多くの治療法は、入手しやすいハーブや植物の治癒力を利用しているため、合成医薬品よりも経済的に入手しやすいです。この手頃な価格は、医療へのアクセスが特定の層にとって課題となりうるインドのような多様な国家では特に有利です。

さらに、伝統的な医薬品は自然で安全であるという認識が、インドの伝統医療市場の需要拡大に大きく寄与しています。多くの人々は、自然界に起源を持つハーブ療法を信頼しています。この信頼は、特定のハーブ療法の有効性と安全性を裏付ける実証的証拠を提供する統合医療研究によってさらに強化されています。例えば、ウコンはその抗炎症作用が世界的に認められており、科学的な研究によってその数々の健康効果が検証されています。

要するに、インドの伝統医療市場の拡大は、経済性、文化性、安全性、知識主導の要素の相乗効果によって推進されているのです。これらの要素が相まって、伝統医療は国民の多様なニーズと嗜好に応える、この国のヘルスケアに不可欠な要素となっています。

当レポートでは、インドの伝統医療市場について調査し、市場の概要とともに、医療システム別、サブセクター別、由来別、用途別、投与経路別、流通チャネル別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 インド伝統医療市場の見通し、2017年～2031年

• 市場規模と予測
• 医療システム別
• サブセクター別
• 由来別
• 用途別
• 投与経路別
• 流通チャネル別
• 地域別
• 企業別市場シェア（％）、2023年

第6章 市場マッピング、2023年

第7章 マクロ環境と産業構造

• 供給需要分析
• 輸出入分析
• バリューチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第8章 市場力学

第9章 規制枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要参入企業の見通し

• Himalaya Wellness Company
• Dabur India Ltd.
• Patanjali Ayurved Ltd.
• Shree Baidyanath Ayurved Bhawan Pvt. Ltd.
• Hamdard Laboratories
• Dr. Reckeweg & Co.
• Dr Willmar Schwabe India Pvt. Ltd.
• Ayyebi Dawakhana Unani Pvt. Ltd.
• SBL Pvt. Ltd.
• Hahnemann Scientific Laboratory
• Tamil Nadu Medicinal Plant Farms and Herbal Medicine Corporation Ltd.
• The Indian Medical Practitioners Co-operative Pharmacy and Stores Ltd.

第14章 戦略的提言

第15章 お問い合わせと免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. India Traditional Medicine Market, By Value, In USD Billion, FY2017-FY2031F
• Figure 2. India Traditional Medicine Market, By Volume, In Million Units, FY2017-FY2031F
• Figure 3. India Traditional Medicine Market Share (%), By System of Medicine, FY2017-FY2031F
• Figure 4. India Traditional Medicine Market Share (%), By Sub-sectors, FY2017-FY2031F
• Figure 5. India Traditional Medicine Market Share (%), By Source, FY2017-FY2031F
• Figure 6. India Traditional Medicine Market Share (%), By Application, FY2017-FY2031F
• Figure 7. India Traditional Medicine Market Share (%), By Route of Administration, FY2017-FY2031F
• Figure 8. India Traditional Medicine Market Share (%), By Distribution Channel, FY2017-FY2031F
• Figure 9. India Traditional Medicine Market Share (%), By Region, FY2017-FY2031F
• Figure 10. By System of Medicine Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 11. By Sub-sectors Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 12. By Source Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 13. By Application Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 14. By Route of Administration Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 15. By Distribution Channel Map-Market Size (USD Billion) & Growth Rate (%), FY2023
• Figure 16. By Region Map-Market Size (USD Billion) & Growth Rate (%), FY2023

India traditional medicine market size was valued at USD 27.53 billion in FY2023, which is expected to reach USD 73.19 billion in FY2031, with a CAGR of 13% for the forecast period between FY2024 and FY2031. The primary drivers behind the growth of India traditional medicine market include cost-effectiveness of traditional medicines, alignment with the patient's personal beliefs, alleviation of concerns about the potential side effects of synthetic drugs, fulfilment of a desire for individualized healthcare, facilitation of broader public access to health knowledge, prevalent perception of being both natural and safe, and the efficacy and safety of certain herbal remedies being backed by integrative health research.

The expansion of India traditional medicine market is rooted in a complex interplay of factors that deeply resonate with both patients and the healthcare sector. A fundamental driving force is the cost-effectiveness inherent in traditional medicinal practices. Many remedies harness the healing power of readily available herbs and plants, rendering them more economically accessible than synthetic pharmaceuticals. This affordability is especially advantageous in a nation as diverse as India, where healthcare access can pose challenges for certain demographics.

Furthermore, the perception of traditional medicines as being natural and safe significantly contributes to the growing demand in India's traditional medicine market. Many individuals trust herbal remedies due to their origins in the natural world. The trust is further reinforced by integrative health research, which provides empirical evidence supporting the effectiveness and safety of specific herbal treatments. For example, turmeric has received global recognition for its anti-inflammatory properties, with scientific studies validating its numerous health benefits.

In essence, the expansion of India's traditional medicine market is propelled by the synergy of economic, cultural, safety, and knowledge-driven elements. These elements collectively establish traditional medicine as an indispensable component of the nation's healthcare landscape, catering to its population's diverse needs and preferences.

Increasing Prevalence of Chronic Diseases

The prevalence of chronic diseases in India has been steadily increasing, posing a significant public health challenge. Studies have revealed high rates of diabetes and hypertension across the country, with diabetes affecting more than 100 million people and hypertension accounting for more than 188.3 million people. Notably, among 18 to 25-year-olds, the prevalence of hypertension is as high as 12%. These conditions are more prevalent in urban areas and worse among the elderly. The burden of chronic diseases is particularly pronounced in urban areas, where 29% of the elderly are affected, compared to 17% in rural areas. Hypertension and diabetes account for a substantial proportion of chronic diseases, with heart disease, acute upper respiratory tract disease, asthma, and stroke contributing to the overall prevalence.

The increasing prevalence of chronic diseases in India has contributed to a rising demand for traditional medicines. Traditional medicines, especially Ayurveda, have gained popularity in India and amidst other countries. The market for medicinal plants in India is growing, with a significant increase in demand for herbal and value-added extracts of medicinal herbs, both domestically and in foreign markets.

Growing Desire for Individualized Healthcare

The desire for individualized healthcare has caused a great surge in India's traditional medicine market. The traditional medicinal systems provide a customized healthcare approach that considers an individual's unique constitution, lifestyle, and health requirements. In contrast to the one-size-fits-all approach of modern medicine, traditional systems like Ayurveda recognize the distinctiveness of each person and the necessity for a personalized treatment regime. These systems often evaluate a patient's physical, mental, and emotional well-being, including diet, environment, and personality traits. By prioritizing individualized care, traditional medicines target specific ailments and strive to enhance overall balance and well-being. The comprehensive approach appeals to many individuals seeking a more tailored and holistic healthcare experience.

Heightened Emphasis on Integrative Health Research

Increased focus on integrative medicine research contributes to the expansion of India traditional medicine market. There is a rising acknowledgment of integrative medicine's potential benefits as individuals seek holistic healthcare solutions. Both patients and healthcare professionals are growing interested in blending conventional medical practices with complementary therapies to create well-rounded and personalized treatment strategies. Consequently, research in the field is crucial for validating these assertions and guaranteeing safety, effectiveness, and seamless integration of evidence-based techniques into mainstream healthcare systems, ultimately leading to improved patient outcomes. In May 2023, The Ministry of Ayush and Indian Council of Medical Research (ICMR) inked a Memorandum of Understanding (MoU) to foster and jointly engage in integrative health research. The MoU is centered on prioritized areas of national significance in healthcare and aims to stimulate impactful research that generates evidence using contemporary scientific methodologies. The collaboration will enhance research capabilities by providing training opportunities for Ayush researchers.

Government Initiatives

A significant portion of the accolades for the expansion of India traditional medicine market can be attributed to the Indian government, which has undertaken numerous initiatives to foster traditional medicine systems. India has entered into international agreements and partnerships to advance traditional medicine on a global scale, exemplified by Memorandums of Understanding (MoU) with nations like the United States and Russia, fostering collaborative research and exchange programs in the traditional medicine domain. Public awareness campaigns and initiatives are systematically executed to enlighten the population about traditional medicine's merits and stimulate its widespread embrace.

These initiatives frequently entail the organization of workshops, seminars, and public health campaigns. A significant move occurred in March 2022 when the Government of India inked a deal with the World Health Organization (WHO) to establish the WHO Global Center for Traditional Medicine in Jamnagar, Gujarat, India. It is an international hub of traditional medical knowledge, backed by a substantial investment of USD 250 million from the Indian government, geared toward leveraging the worldwide potential of traditional medicine by merging it with modern science and technology. The overarching goal is to enhance both human health and environmental well-being.

Ayurveda is Dominating India Traditional Medicine Market

The ayurvedic sector plays a dominant role in propelling the expansion of India traditional medicine market. The growth is propelled by several key factors, including a surging demand for genuine ayurvedic medicinal offerings, heightened consumer awareness, and increasing emphasis on health and well-being. In contrast to prescription medications, Ayurvedic products are known for their minimal risk of causing severe side effects while demonstrating efficacy in addressing chronic ailments. India is presented with a remarkable opportunity to harness the economic potential of the

Ayurvedic pharmaceutical industry, driven by a clear purpose and substantial demand, both domestically and internationally. Numerous prominent companies are striving to capitalize on the future growth potential of India traditional medicine market, which will be shaped by the increasing levels of disposable income and the changing lifestyle trends. In January 2023, Dabur India unveiled its commitment to promote Ayurveda among contemporary consumers. They introduced two products, namely the premium sugar-free health revitalizer, called Ratnaprash Sugar-Free and the ayurvedic digestive tonic, known as Aampachak kadha, during the 9th World Ayurveda Congress & International AROGYA EXPO held in Goa.

Sustained Interest in Herbal Goods

Herbal products account for a significant portion of the traditional medicine market in India. Large pharmaceutical corporations in India are steadily establishing a presence in the expanding market for herbal medicines. The development is driven by consumers' increasing preference for high-quality natural treatments associated with well-known brands. The demand for herbal dietary supplements has surged due to consumers embracing natural preventive solutions for various health issues. The shift has gained significant attention in 2020 during the global pandemic, with individuals seeking stress relief and immune system support, consequently driving up the sales of herbal dietary supplements. For instance, in May 2023, Himalaya Wellness, a brand specializing in herbal supplements and plant-based personal care products, launched its Ashwagandha+ supplement range while expanding its Hello product line with three new offerings. One of these additions was Himalaya's Ashwagandha+ Focus, crafted to enhance memory and concentration. This formulation, containing ashwagandha, bacopa, rosemary, and green tea, promotes cognitive function.

Key Players Landscape and Outlook

Pharmaceutical giants are strategically acquiring Indian ayurvedic enterprises in response to shifting consumer preferences causing a great shift in India traditional medicine market. Traditional medicinal systems have experienced a revival in popularity, driven by consumers' growing interest in natural and comprehensive healthcare alternatives. By acquiring well-established ayurvedic companies, pharmaceutical giants can enter this expanding market, presenting an array of herbal and ayurvedic products that resonate with consumers' preferences for natural remedies. The calculated maneuver diversifies pharmaceutical firms' product portfolios and allow them to harness the trust and heritage associated with these local Ayurvedic brands. Hence, they meet the emerging needs of health-conscious consumers who are increasingly exploring alternative and complementary therapeutic options.

In November 2022, Mankind Pharma Ltd. made a significant investment by acquiring a majority stake in Upakarma Ayurveda Pvt Ltd through one of its subsidiaries, for an undisclosed amount. Mankind Pharma's commitment to enhancing healthcare services led to its partnership with Upakarma Ayurveda, which is aimed at meeting the evolving demands of consumers.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. India Traditional Medicine Market Outlook, FY2017-FY2031F

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. By System of Medicine
  • 4.2.1. Ayurveda
  • 4.2.2. Yoga
  • 4.2.3. Naturopathy
  • 4.2.4. Unani
  • 4.2.5. Siddha
  • 4.2.6. Homeopathy
• 4.3. By Sub-sectors
  • 4.3.1. Herbal Plants
  • 4.3.2. Nutraceuticals
  • 4.3.3. Cosmeceuticals
  • 4.3.4. Pharmaceuticals
  • 4.3.5. Plant Derivatives
  • 4.3.6. Plant Extracts
• 4.4. By Source
  • 4.4.1. Plants
  • 4.4.2. Animals
  • 4.4.3. Metals
  • 4.4.4. Minerals
• 4.5. By Application
  • 4.5.1. Neurovascular
  • 4.5.2. Cardiovascular
  • 4.5.3. Dermatology
  • 4.5.4. Oncology
  • 4.5.5. Respiratory
  • 4.5.6. Diabetology
  • 4.5.7. Others
• 4.6. Route of Administration
  • 4.6.1. Oral route
  • 4.6.2. Nasal route
  • 4.6.3. Ocular route
  • 4.6.4. Otic route
  • 4.6.5. Cutaneous route
  • 4.6.6. Others
• 4.7. By Distribution Channel
  • 4.7.1. Hospital Pharmacy
  • 4.7.2. Retail Pharmacy
  • 4.7.3. Online Pharmacy
  • 4.7.4. AYUSH Health & Wellness Centre
• 4.8. By Region
  • 4.8.1. North
  • 4.8.2. South
  • 4.8.3. East
  • 4.8.4. West & Central
• 4.9. By Company Market Share (%), FY2023

6. Market Mapping, FY2023

• 6.1. By System of Medicine
• 6.2. By Sub-sectors
• 6.3. By Source
• 6.4. By Application
• 6.5. By Route of Administration
• 6.6. By Distribution Channel
• 6.7. By Region

7. Macro Environment and Industry Structure

• 7.1. Supply Demand Analysis
• 7.2. Import Export Analysis
• 7.3. Value Chain Analysis
• 7.4. PESTEL Analysis
  • 7.4.1. Political Factors
  • 7.4.2. Economic System
  • 7.4.3. Social Implications
  • 7.4.4. Technological Advancements
  • 7.4.5. Environmental Impacts
  • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5. Porter's Five Forces Analysis
  • 7.5.1. Supplier Power
  • 7.5.2. Buyer Power
  • 7.5.3. Substitution Threat
  • 7.5.4. Threat from New Entrant
  • 7.5.5. Competitive Rivalry

8. Market Dynamics

• 8.1. Growth Drivers
• 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

• 9.1. Clinical Trials
• 9.2. Patent Landscape
• 9.3. Regulatory Approvals
• 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

• 10.1. Competition Matrix of Top Five Market Leaders
• 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, FY2023)
• 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4. SWOT Analysis (For Five Market Players)
• 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

• 13.1. Himalaya Wellness Company
  • 13.1.1. Company Details
  • 13.1.2. Key Management Personnel
  • 13.1.3. Products & Services
  • 13.1.4. Financials (As reported)
  • 13.1.5. Key Market Focus & Geographical Presence
  • 13.1.6. Recent Developments
• 13.2. Dabur India Ltd.
• 13.3. Patanjali Ayurved Ltd.
• 13.4. Shree Baidyanath Ayurved Bhawan Pvt. Ltd.
• 13.5. Hamdard Laboratories
• 13.6. Dr. Reckeweg & Co.
• 13.7. Dr Willmar Schwabe India Pvt. Ltd.
• 13.8. Ayyebi Dawakhana Unani Pvt. Ltd.
• 13.9. SBL Pvt. Ltd.
• 13.10. Hahnemann Scientific Laboratory
• 13.11. Tamil Nadu Medicinal Plant Farms and Herbal Medicine Corporation Ltd. (TAMPCOL)
• 13.12. The Indian Medical Practitioners Co-operative Pharmacy and Stores Ltd. (IMPCOPS)

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer